Диабеталонг® 30 мг таблетки с модифицированным высвобождением

Country: Kyrgyzstan

Language: Russian

Source: Правительства Кыргызской Республики (Департамент лекарственного обеспечения и медицинской техники)

Active ingredient:

Гликлазид

Available from:

ОАО "Синтез" (ОАО "Синтез")

ATC code:

A10BB09

INN (International Name):

Gliclazide

Dosage:

30 мг

Pharmaceutical form:

таблетки с модифицированным высвобождением

Units in package:

№60

Prescription type:

по рецепту

Manufactured by:

ОАО "Синтез" (Россия)

Therapeutic area:

Гипогликемическое средство из группы производных сульфонилмочевины II поколения

Product summary:

ПЖВЛС: нет

Authorization date:

2017-08-30

Summary of Product characteristics

                                lfepnrtfi r
Iena
o0ecIIeqeH
M
[yfturentl
,Af
"
I,IHCTPYKUIIfl
TIOMEAI,IqI,IHCKOMYIIPI,IMEHEHI,IIOJIEKAPCTBEHHOI
O
CEACTBA
AI,IAEETAJIOHT@
Perucrpaquonnrrfi
HoMep:
Topronoe
Ha3BaHue
Aua6eraronr@
MexgynapoAHoe
HerIareHToBaHHoe
Ha3BaHLIe
fnarragraA
JlerapcrnenHas
Sopnra
Ta6rerru
c rr,ro4Ia
$urlLIpoBaHHbIM
errcno
6o
xAeHkI
eM
Cocras
na 1 ra6rerrcy:
Arcmueuoe
6eu4ecm6o:
fJIHKJIa3LIA
-
30 ur;
BcnouozamerbHbte
6eu4ecmca.'
D.rnpoMenno:a
(ltetoqer
K 100 LV CR
Premium)
-
74 Mr,
KpeMHI4t
Ar{oKcr,rA
KonnoprAHbrft
(aepocun)
-
1 ur,
KanbIILIt
creapar
-
2
wr, TaJIbK
-
6
tr,r, JIaKTo3bI
MoHorr{Apar
(ra6nemo:a
80)
-
87 ur.
Ouucanue
Ta6lerxu
6eloro
r4Jrlr
roqrr,r
6eroro
rlBera,
IInocKoIIITJII4HAp[qecKvre,
c
(facrofi.
,{onycxaercx
HAJII,ITII,IE
(MPAMOPHOCTI,I).
OapvrarcoreparleBTlrqecKafl
rpyrrrra
€axapocnuxarcq[e
npelaparbl
An.s
nepopanbHoro
cynrf
oHurMoueBI4HbI.
frzKrasl,IA.
Koa
ATX A10BB09
rrpr.rMeHeHa.s.
llpozsno4Hue
Oapruaro.norlrqecKlre
cnoffcrsa
(DapruarcoglrKaMIrKa
llepopanrnoe
D{norJrkrKeMr4qecKoe
cpeAcrBo,
rrporr3BoAnoe
cynr$oHl,InMoqeBunrt
II rIoKoJIeHI4t.
Crunrylupyer
ceKperlr4ro
r{HcyJrr.{Ha
rrolxery4ovnoft
xere3ofi,
cHI,IXaer
ypoBeHb
rJIIoKo3bI
B
KpoBr4,
ycanr4Baer rrHcynr{HoceKperopHoe
Aeficreze
fnloKo3bl
v
noBbllrlaer
qyBcrBI4TeJIbHocrb
nepu$epuuecKrrx
rxaHefi
K r,rucynr4Hy.
llocre
2
ter
reqeHl,It
y
6onrruuHcrBa
IIaIIpIeHToB
He
pa3Br4Baercs
[puBbrKaHLrA
K npelapary
(coxpanrercs
[oBbIUreHI4e
ypoBHt
nocrnpaHAlrulJlbHoro
vncy nvHa
I4 ceKpeIIH.a
C-nenru4oe).
Corparqaer
[poMexyroK
BpeMeHr4
or
MoMeHTa
npl4eMa
II4IIITI
Ao
Haqana
ceKpeUI4tI
I{Hcyn}IHa.
BoccranasJlI4Baer
panttuit rrr{K ceKperllauu:ncynuHa
B orBer
Ha rlocrynneHlre
fnloKoart
(n
ornI,IrIHe
or
Apyr[x
[pot43BoAHbrx
cylr$onnnMorreBr,rHbr,
Koropble
oKa3bIBaIor
4efictnue,
fJIaBHbIM
o6pa:owr,
B xoAe nropofi
craptvlzr
cerpeqzz).
Tarcxe
ycunllBaer
Bropyrc
Sa:y
cexpelJuLrrrmcynr4na.
YTBEPX{,AAIO
v
Vuenruaer
rrlrK
rr4rrepfnr4KeMurla
nocJre nppreMa rrrrqu
(cHuxaer
nocrrrpaHAr.ranbHyro
rIanepfnrrKerrruro).
frurrasLrA
rroBbrrrraer
rryBcrBr.rreJrbHocrb
nepu(pepra.recKlrx
r
                                
                                Read the complete document
                                
                            

Documents in other languages